Hiroyuki Michiwaki
Research Subjects
Research Interests
Hiroyuki Michiwaki has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Hisato Shima
Department of Nephrology and Hypertension, Kamei Hospital
1 shared publication - Jun Minakuchi
Department of Nephrology, Kawashima Hospital, Tokushima, Japan, Japan
1 shared publication - Kazuyoshi Okada
Department of Nephrology, Kawashima Hospital
1 shared publication - Manabu Tashiro
Department of Kidney Disease, Kawashima Hospital, Tokushima, Japan
1 shared publication - Tomoko Inoue
Department of Nephrology, Kawashima Hospital, Tokushima, Japan, Japan
1 shared publication - Toshio Doi
Department of Nephrology, Kawashima Hospital, 6-1 Kitasakoichiban-Cho, Tokushima-City 770-0011, Japan
1 shared publication
Latest Publications
- Open Access
- 24 March 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (7) , 1865
Impact of Albumin Leakage on the Mortality of Patients Receiving Hemodialysis or Online Hemodiafiltration
Background: Online hemodiafiltration (OHDF) has a lower mortality rate than hemodialysis (HD). We aimed to investigate the impact of the albumin leakage on the mortality of patients receiving HD or OHDF. Methods: In this single-center study, consecutive patients receiving renal replacement therapy between January and April 2018 were retrospectively registered. Using (1:1) propensity score matching, 3-year all-cause mortality was compared between patients receiving HD and OHDF, and the impact of albumin leakage on the mortality rate in both groups was investigated. Results: Of the 460 patients, 137 patients receiving HD were matched with an equal number of patients receiving OHDF. OHDF was associated with higher albumin leakage (p < 0.001) and a lower mortality than HD (log-rank test, p < 0.001). Albumin leakage was associated with mortality in patients receiving HD (per 1 g increase, hazard ratio (HR): 0.495, 95% confidence interval (CI): 0.275–0.888) and patients receiving OHDF (per 1 g increase, HR: 0.734, 95% CI: 0.588–0.915). Patients receiving HD, with the highest albumin leakage tertile (>3 g), had a similar mortality rate to patients receiving OHDF, with similar albumin leakage. Conclusions: The negative relationship between albumin leakage and mortality suggests the benefit of removing middle- to -large-molecular-weight substances to improve survival.
- 24 March 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (7) , 1865
Open AccessImpact of Albumin Leakage on the Mortality of Patients Receiving Hemodialysis or Online Hemodiafiltration
Background: Online hemodiafiltration (OHDF) has a lower mortality rate than hemodialysis (HD). We aimed to investigate the impact of the albumin leakage on the mortality of patients receiving HD or OHDF. Methods: In this single-center study, consecutive patients receiving renal replacement therapy between January and April 2018 were retrospectively registered. Using (1:1) propensity score matching, 3-year all-cause mortality was compared between patients receiving HD and OHDF, and the impact of albumin leakage on the mortality rate in both groups was investigated. Results: Of the 460 patients, 137 patients receiving HD were matched with an equal number of patients receiving OHDF. OHDF was associated with higher albumin leakage (p < 0.001) and a lower mortality than HD (log-rank test, p < 0.001). Albumin leakage was associated with mortality in patients receiving HD (per 1 g increase, hazard ratio (HR): 0.495, 95% confidence interval (CI): 0.275–0.888) and patients receiving OHDF (per 1 g increase, HR: 0.734, 95% CI: 0.588–0.915). Patients receiving HD, with the highest albumin leakage tertile (>3 g), had a similar mortality rate to patients receiving OHDF, with similar albumin leakage. Conclusions: The negative relationship between albumin leakage and mortality suggests the benefit of removing middle- to -large-molecular-weight substances to improve survival.